Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Cenci

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Blood|January 24, 2009
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibitionGiada Bianchi, Laura Oliva, Paolo Cascio, et al.
Plos One|September 27, 2013
Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cellsHolger W Auner, Anne Marie Moody, Theresa H Ward, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 20, 2022
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetesElisa Cairoli, Giorgia Grassi, Agostino Gaudio, et al.
The EMBO Journal|February 25, 2006
Progressively impaired proteasomal capacity during terminal plasma cell differentiationSimone Cenci, Alexandre Mezghrani, Paolo Cascio, et al.
Aging Cell|February 14, 2026
The HIF-1α Pathway Regulates Satellite Cell Fate During Aging Through Histone LactylationMarco Piccoli, Lorenzo Mornatti, Ivana Lavota, et al.
Journal of Medicinal Chemistry|October 2, 2010
A new fluorogenic peptide determines proteasome activity in single cellsSilvana A M Urru, Pietro Veglianese, Ada De Luigi, et al.
Blood|January 29, 2017
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicityLaura Oliva, Ugo Orfanelli, Massimo Resnati, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2013
MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunityElisa Benasciutti, Elisabetta Mariani, Laura Oliva, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panelIacopo Chiodini, Agostino Gaudio, Andrea Palermo, et al.
Ageing Research Reviews|August 30, 2023
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspectiveStefano Salvioli, Maria Sofia Basile, Leonardo Bencivenga, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Blood|January 24, 2009
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibitionGiada Bianchi, Laura Oliva, Paolo Cascio, et al.
Plos One|September 27, 2013
Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cellsHolger W Auner, Anne Marie Moody, Theresa H Ward, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 20, 2022
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetesElisa Cairoli, Giorgia Grassi, Agostino Gaudio, et al.
The EMBO Journal|February 25, 2006
Progressively impaired proteasomal capacity during terminal plasma cell differentiationSimone Cenci, Alexandre Mezghrani, Paolo Cascio, et al.
Aging Cell|February 14, 2026
The HIF-1α Pathway Regulates Satellite Cell Fate During Aging Through Histone LactylationMarco Piccoli, Lorenzo Mornatti, Ivana Lavota, et al.
Journal of Medicinal Chemistry|October 2, 2010
A new fluorogenic peptide determines proteasome activity in single cellsSilvana A M Urru, Pietro Veglianese, Ada De Luigi, et al.
Blood|January 29, 2017
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicityLaura Oliva, Ugo Orfanelli, Massimo Resnati, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2013
MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunityElisa Benasciutti, Elisabetta Mariani, Laura Oliva, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Management of bone fragility in type 2 diabetes: Perspective from an interdisciplinary expert panelIacopo Chiodini, Agostino Gaudio, Andrea Palermo, et al.
Ageing Research Reviews|August 30, 2023
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspectiveStefano Salvioli, Maria Sofia Basile, Leonardo Bencivenga, et al.
Pageof 7